The Idiopathic Hypersomnia Treatment Market is estimated to be valued at US$ 242.4 Million in 2022 and is expected to exhibit a CAGR Of 8.7% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Idiopathic hypersomnia is a chronic neurological disorder characterized by excessive daytime sleepiness that is not caused by...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian